Rotator Cuff Tendinopathy
Investigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; case-series evidence for pain reduction.
Patienten-Zusammenfassung
- Ist dies FDA-zugelassen fuer diese Anwendung?
- Not FDA-cleared for rotator-cuff tendinopathy. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for shoulder tendinopathy is investigational.
- Welche Evidenz existiert?
- Tier C (investigational). Small case series report shoulder pain-score and range-of-motion improvement after 2-4 sessions. There are no randomized controlled trials specific to rotator-cuff tendinopathy (the related Tier B entry for lateral-epicondylitis is the lone tendinopathy with RCT support). Evidence-based first-line care is structured physiotherapy and graded exercise; corticosteroid or platelet-rich plasma injections, subacromial decompression, or rotator-cuff repair are reserved for refractory or torn cases.
- Hauptrisiken
- Bleeding from bite sites for 6 to 24 hours after detachment
- Bruising and tenderness over the shoulder for 5 to 10 days
- Itching and irritation at bite sites for days to weeks
- Local skin infection or, rarely, Aeromonas infection
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of shoulder pain for 1 to 2 days after the session
- Small permanent scars at bite sites
- Wer dies nicht in Betracht ziehen sollte
- Patients on blood thinners (warfarin INR >2.0, DOACs, heparin)
- Patients with hemophilia or other bleeding disorders
- Patients with severe anemia (Hb <10 g/dL)
- Patients with full-thickness rotator-cuff tear requiring surgical evaluation
- Patients with acute septic arthritis or active joint infection
- Patients with a recent corticosteroid injection within 4 weeks
- Patients with a weakened immune system
- Was Sie Ihren Kliniker fragen sollten
- Have I been evaluated by orthopedics or sports medicine with imaging (ultrasound or MRI)?
- Do I have a tendinopathy, partial tear, or full-thickness tear — and what is the right treatment for each?
- Have I completed a structured physical-therapy program of at least 12 weeks?
- What evidence supports leech therapy for rotator-cuff tendinopathy specifically?
- What is the practitioner's experience and Aeromonas-prevention plan?
- What is the realistic chance of benefit, and for how long?
- What is the cost?
- Wann dringende medizinische Versorgung suchen
- Sudden inability to lift the arm after trauma (possible acute tear)
- Fever, hot swollen shoulder joint (possible septic arthritis)
- Spreading redness, warmth, pus, or red streaks (cellulitis)
- Bleeding from a bite site lasting more than 24 to 48 hours
- Fever above 38.0 C / 100.4 F or chills
- Hives, throat tightness, or breathing difficulty
Was dies NICHT bedeutet
- This is not FDA-cleared for rotator-cuff tendinopathy.
- Small uncontrolled case series are not evidence of efficacy versus structured physiotherapy.
- Mechanism rationale (local anti-inflammation) does NOT establish clinical efficacy.
- Leech therapy does NOT repair tendon tears or address underlying biomechanics.
- Leech therapy is not a substitute for orthopedic evaluation when a tear is suspected.
Sicherheits-Querverweise
Clinical Profile
- Category
- musculoskeletal
- ICD-10
- M75.30, M75.31, M75.32, M75.100, M75.121
- Safety tier
- low
Evidence Summary
No controlled clinical trial or credible case series of leech therapy for rotator cuff tendinopathy has been published; there is no reliable evidence of reduction in VAS pain or improvement in SPADI scores. Any proposed local anti-inflammatory mechanism is speculative and unproven in this condition. Evidence-based care — a structured physiotherapy program (scapular stabilization and progressive rotator cuff strengthening), analgesia, and consideration of corticosteroid injection — remains first-line, and patients with full-thickness tears or a surgical indication should be referred for orthopedic evaluation. ASH position: any use of leech therapy for rotator cuff tendinopathy is investigational and mechanistic only.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Yildirim MA et al. (2016), n=24
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Full-thickness rotator cuff tear with surgical indication
- Active calcific tendinopathy with severe acute pain (needle barbotage preferred)
Related Conditions
Knee Osteoarthritis
Off-label use with three RCTs showing pain and function improvement comparable to NSAID gel at 3 months in mild-to-moderate symptomatic knee OA.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
Off-label use with RCT evidence: single-session leech therapy reduces pain and improves function in CMC-1 (basal thumb) OA at 8 weeks.
Lateral Epicondylitis (Tennis Elbow)
Off-label use with two RCTs showing significant pain reduction at 7-12 weeks compared to topical NSAID and conventional physiotherapy.
Plantar Fasciitis
Off-label use with one RCT showing significant heel pain reduction at 6 weeks compared to conservative care.